The Food and Drug Administration has cleared Vesticon Corp.'s Omniax device to market in the United States. The device is the first ever cleared nationally to assist in the diagnosis and treatment of balance disorders and vertigo, including benign paroxysmal positional vertigo. Read the rest of the story online in the Portland Business Journal.